News
-
Alliance
C4U and iXgene execute a collaborative research agreement
-
Alliance
C4U and Cyto-Facto enter into Collaborative Research Agreement
-
Alliance
C4U and Sumitomo Pharma enter into License Agreement
-
Alliance
C4U and Celaid Therapeutics have executed a collaborative research agreement for a hematopoietic stem cell gene therapy product.
-
Alliance
C4U and The Center for Aquaculture Technologies (CAT) have entered into a collaborative research agreement to explore the application of CRISPR-Cas3 technology in the field of aquaculture.
-
Alliance
C4U and Healiva have entered into a Strategic Alliance Agreement for medical applications of CRISPR-Cas3 technology.
-
Alliance
C4U enters into Non-Exclusive Sublicense Agreement with Rege Nephro
-
Alliance
C4U and Inplanta Innovations enter into Collaborative Research and Alliance Agreement
-
Alliance
C4U Corporation has raised a total of 1.5 billion JPY (approximately $11 million at the then-effective exchange rate) for its Series B financing.
-
Alliance
C4U and Brain Research Institute, Niigata University have entered into the collaborative research agreement for a novel gene therapy utilizing CRISPR -Cas3 technology.